Fraunhofer-Institute of Toxicology and Experimental Medicine
38
1
1
35
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.6%
1 terminated/withdrawn out of 38 trials
97.2%
+10.7% vs industry average
3%
1 trials in Phase 3/4
0%
0 of 35 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (38)
Biosensor and Environmental Sensor Development Within the REMEDIA Project
Role: lead
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
Role: lead
Follow-up-study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers
Role: lead
Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis
Role: lead
Use of Exhaled Particles to Assess Lung Pharmacokinetics
Role: lead
Impact of Carrier Solutions for House Dust Mite Allergen on Allergic Reactions
Role: lead
Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients
Role: lead
Second Follow-up Study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers
Role: lead
Characterization of Aerosol Generation and Transport in the Human Lung of Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Role: lead
SHAPES: Supporting Multimorbid Older People
Role: collaborator
Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects
Role: lead
Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19
Role: lead
Characterization of the Inhibitory Effects of Fevipiprant (QAW039) on Activation of Eosinophils and ILC2 Cells by Prostaglandin D2 Metabolites
Role: lead
Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms
Role: lead
Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)
Role: lead
Evaluation of Nasal Inflammatory Biomarkers
Role: lead
Pharmacokinetics of Enrofloxacin in Plasma and Urine
Role: lead
Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers
Role: lead
Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis
Role: lead
Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum
Role: lead